Skye Bioscience
SKYE
SKYE
57 hedge funds and large institutions have $78.1M invested in Skye Bioscience in 2025 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 7 increasing their positions, 20 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
1.7% less ownership
Funds ownership: 65.86% → 64.16% (-1.7%)
8% less capital invested
Capital invested by funds: $85.3M → $78.1M (-$7.13M)
65% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 20
Holders
57
Holding in Top 10
2
Calls
$2.32M
Puts
$119K
Top Buyers
| 1 | +$579K | |
| 2 | +$418K | |
| 3 | +$351K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$176K |
| 5 |
Two Sigma Investments
New York
|
+$115K |
Top Sellers
| 1 | -$909K | |
| 2 | -$842K | |
| 3 | -$522K | |
| 4 |
Millennium Management
New York
|
-$269K |
| 5 |
PIM
Platinum Investment Management
Sydney Australia 2000,
Australia
|
-$237K |
